{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:39:33Z","timestamp":1789389573301,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11914-008-0014-8","type":"journal-article","created":{"date-parts":[[2008,10,12]],"date-time":"2008-10-12T03:35:19Z","timestamp":1223782519000},"page":"77-83","source":"Crossref","is-referenced-by-count":90,"title":["Parathyroid hormone and the cardiovascular system"],"prefix":"10.1007","volume":"6","author":[{"given":"Lorraine A.","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,11]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","volume":"82","author":"S. Ljunghall","year":"1997","unstructured":"Ljunghall S, Abela C, Frank H, et al.: Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997, 82:106\u2013112.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01658740","volume":"15","author":"G.M. Hedback","year":"1998","unstructured":"Hedback GM, Oden AS: The influence of surgery on the risk of death in patients with hyperparathyroidism. World J Surg 1998, 15:399\u2013405.","journal-title":"World J Surg"},{"key":"14_CR3","first-page":"1","volume":"102","author":"M. Palmer","year":"1987","unstructured":"Palmer M, Adami HO, Bergstrom R, Akerstrom G: Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987, 102:1\u20137.","journal-title":"Surgery"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","volume":"104","author":"R.A. Wermers","year":"1998","unstructured":"Wermers RA, Khosla S, Atkinson EJ, et al.: Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998, 104:115\u2013122.","journal-title":"Am J Med"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00268-001-0285-z","volume":"26","author":"H. Vestergaard","year":"2002","unstructured":"Vestergaard H, Ostergaard Kristensen L: Normocalcemia and persistent elevated serum concentrations of 1\u201384 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease. World J Surg 2002, 26:657\u2013660.","journal-title":"World J Surg"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","volume":"28","author":"C.G. Ogard","year":"2004","unstructured":"Ogard CG, Engholm MS, Almdal TP, Vestergaard H: Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 2004, 28:108\u2013111.","journal-title":"World J Surg"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","volume":"11","author":"E. Kamycheva","year":"2004","unstructured":"Kamycheva E, Sundsfjord J, Jorde R: Serum parathyroid hormone levels predict coronary heart disease: the Troms\u00f8 Study. Eur J Cardiovasc Prev Rehabil 2004, 11:69\u201374.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-4356(97)00104-2","volume":"50","author":"L. Lind","year":"1997","unstructured":"Lind L, Skarfors E, Berglund L, et al.: Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997, 50:967\u2013973.","journal-title":"J Clin Epidemiol"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.34.3.484","volume":"34","author":"R. Jorde","year":"1999","unstructured":"Jorde R, Sundsfjord J, Fitzgerald P, Bonaa KH: Serum calcium and cardiovascular risk factors and diseases: the Troms\u00f8 study. Hypertension 1999, 34:484\u2013490.","journal-title":"Hypertension"},{"key":"14_CR10","first-page":"2149","volume":"81","author":"B.G. Leifsson","year":"1996","unstructured":"Leifsson BG, Ahren B: Serum calcium and survival in a large health-screening program. J Clin Endocrinol Metab 1996, 81:2149\u20132153.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2006.08.027","volume":"194","author":"M.R. Rubin","year":"2007","unstructured":"Rubin MR, Rundek T, McMahon DJ, et al.: Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis 2007, 194:426\u2013432.","journal-title":"Atherosclerosis"},{"key":"14_CR12","first-page":"1815","volume":"85","author":"G. Barletta","year":"2000","unstructured":"Barletta G, De Feo ML, Del Bene R, et al.: Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85:1815\u20131821.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2007.01778.x","volume":"261","author":"M.B. Snijder","year":"2007","unstructured":"Snijder MB, Lips P, Seidell JC, et al.: Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007, 261:558\u2013565.","journal-title":"J Intern Med"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.35.5.1154","volume":"35","author":"R. Jorde","year":"2000","unstructured":"Jorde R, Sundsfjord J, Haug E, B\u00f8naa KH: Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000, 35:1154\u20131159.","journal-title":"Hypertension"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00004872-199715110-00011","volume":"15","author":"L. Morfis","year":"1997","unstructured":"Morfis L, Smerdely P, Howes LG: Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens 1997, 15:1271\u20131276.","journal-title":"J Hypertens"},{"key":"14_CR16","first-page":"360","volume":"2","author":"H.N. Hulter","year":"1998","unstructured":"Hulter HN, Melby JC, Peterson JC, Cooke CR: Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1998, 2:360\u2013370.","journal-title":"J Clin Hypertens"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","volume":"12","author":"D. Fliser","year":"1997","unstructured":"Fliser D, Franek E, Fode P, et al.: Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 1997, 12:933\u2013938.","journal-title":"Nephrol Dial Transplant"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","volume":"137","author":"I.L. Nilsson","year":"2005","unstructured":"Nilsson IL, Aberg J, Rastad J, Lind L: Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery 2005, 137:632\u2013638.","journal-title":"Surgery"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0167-5273(92)90227-T","volume":"35","author":"R. Schleiffer","year":"1992","unstructured":"Schleiffer R: Parathyroid hormone and genetic hypertension. Int J Cardiol 1992, 35:303\u2013310.","journal-title":"Int J Cardiol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF02067371","volume":"16","author":"J.J. Sancho","year":"1992","unstructured":"Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A: Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg 1992, 16:732\u2013735.","journal-title":"World J Surg"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1067\/msy.2001.118368","volume":"130","author":"I.L. Nilsson","year":"2001","unstructured":"Nilsson IL, Rastad J, Johansson K, Lind L: Endothelial vasodilatatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001, 130:986\u2013990.","journal-title":"Surgery"},{"key":"14_CR22","first-page":"77","volume":"21","author":"C. Gennari","year":"1995","unstructured":"Gennari C, Nami R, Gonnelli S: Hypertension and primary hyperparathyroidism: role of the adrenergic and plasma renin angiotensin systems. Miner Electrolyte Metab 1995, 21:77\u201381.","journal-title":"Miner Electrolyte Metab"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02509549","volume":"58","author":"P. Lakatos","year":"1996","unstructured":"Lakatos P, Tatra A, Foldes J, et al.: Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism. Calcif Tissue Int 1996, 58:70\u201371.","journal-title":"Calcif Tissue Int"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/00007611-198909000-00014","volume":"82","author":"A.K. Sangal","year":"1989","unstructured":"Sangal AK, Kevwitch M, Rao DS, Rival J: Hypomagnesemia and hypertension in primary hyperparathyroidism. South Med J 1989, 82:1116\u20131118.","journal-title":"South Med J"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1067\/msy.2002.128692","volume":"132","author":"E.G. Almqvist","year":"2002","unstructured":"Almqvist EG, Bondeson AG, Bondeson L, et al.: Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 2002, 132:1126\u20131132.","journal-title":"Surgery"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","volume":"82","author":"T. Stefenelli","year":"1997","unstructured":"Stefenelli T, Abela C, Frank H, et al.: Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997, 82:106\u2013112.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","volume":"50","author":"A. Piovesan","year":"1999","unstructured":"Piovesan A, Molineri N, Casasso F, et al.: Left ventricular hypertrophy in primary hyperparathyroidism: effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999, 50:321\u2013328.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/msy.2000.110240","volume":"128","author":"I.L. Nilsson","year":"2000","unstructured":"Nilsson IL, Aberg J, Rastad J, Lind L: Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism\u2014effects of parathyroidectomy. Surgery 2000, 128:895\u2013902.","journal-title":"Surgery"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00268-005-7740-1","volume":"29","author":"C.G. Ogard","year":"2005","unstructured":"Ogard CG, Sondergaard SB, Vestergaard H, et al.: Myocardial perfusion defects and the left ventricular ejection fraction disclosed scintigraphy in patients with primary hyperparathyroidism. World J Surg 2005, 29:914\u2013916.","journal-title":"World J Surg"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10554-006-9166-8","volume":"23","author":"M. Baykan","year":"2007","unstructured":"Baykan M, Erem C, Erdogan T, et al.: Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007, 23:323\u2013328.","journal-title":"Int J Cardiovasc Imaging"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(00)00130-9","volume":"47","author":"M. Kosch","year":"2000","unstructured":"Kosch M, Hausberg M, Vormbrock K, et al.: Impaired flow-mediated vasodilatation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000, 47:813\u2013818.","journal-title":"Cardiovasc Res"},{"key":"14_CR32","first-page":"2045","volume":"130","author":"D.J. Dipette","year":"1992","unstructured":"Dipette DJ, Christenson W, Nickols MA, Nickols GA: Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology 1992, 130:2045\u20132051.","journal-title":"Endocrinology"},{"key":"14_CR33","first-page":"34","volume":"37","author":"K.D. Schluter","year":"1998","unstructured":"Schluter KD, Piper HM: Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Circ Res 1998, 37:34\u201341.","journal-title":"Circ Res"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI110137","volume":"67","author":"E. Bogin","year":"1981","unstructured":"Bogin E, Massry SG, Harary I: Effects of parathyroid hormone on rat heart cell. J Clin Invest 1981, 67:1215\u20131227.","journal-title":"J Clin Invest"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(25)23122-6","volume":"256","author":"A. Roca-Cusachs","year":"1991","unstructured":"Roca-Cusachs A, Dipette DJ, Nickols G: Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther 1991, 256:110\u2013118.","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1139\/y83-173","volume":"61","author":"T.E. Tenner Jr","year":"1983","unstructured":"Tenner TE Jr, Ramanadham S, Yang MC, Pang PK: Chronotropic actions of bPTH-(1\u201334) in the right atrium of the rat. Can J Physiol Pharmacol 1983, 61:1162\u20131167.","journal-title":"Can J Physiol Pharmacol"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"H1998","DOI":"10.1152\/ajpheart.1993.264.6.H1998","volume":"264","author":"M. Smogorzewski","year":"1993","unstructured":"Smogorzewski M, Zayed M, Zhang YB, et al.: Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 1993, 264:H1998\u2013H2006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1161\/01.CIR.96.10.3704","volume":"96","author":"M. Hara","year":"1997","unstructured":"Hara M, Liu Y, Zhen L, et al.: The positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are due to increases in the current I(f), and the slope of the pacemaker potential. Circulation 1997, 96:3704\u20133709.","journal-title":"Circulation"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/endo-125-2-834","volume":"125","author":"G.A. Nickols","year":"1989","unstructured":"Nickols GA, Nana AD, Nickols MA, et al.: Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology 1989, 125:834\u2013841.","journal-title":"Endocrinology"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1161\/01.CIR.96.10.3704","volume":"96","author":"M. Hara","year":"1997","unstructured":"Hara M, Liu YM, Zhen L, et al.: Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 1997, 96:3704\u20133709.","journal-title":"Circulation"},{"key":"14_CR41","unstructured":"Shimoyama M, Ogino K, Burkhoff D, et al.: Signal transduction pathways and the chronotropic actions of PTH in isolated rat hearts [abstract P-592]. Presented at the 80 th Annual Meeting of the Endocrine Society. New Orleans, LA; June 23\u201327, 1998."},{"issue":"Suppl5","key":"14_CR42","first-page":"T197","volume":"23","author":"M. Shimoyama","year":"1998","unstructured":"Shimoyama M, Ogino K, Taniguchi S, et al.: Signal transduction pathways and chronotropic actions of PTH and its fragments in isolated, perfused rat hearts. Bone 1998, 23(Suppl 5):T197.","journal-title":"Bone"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/endo.136.7.7789328","volume":"136","author":"K. Ogino","year":"1995","unstructured":"Ogino K, Burkhoff D, Bilezikian JP: The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1995, 136:3024\u20133030.","journal-title":"Endocrinology"},{"key":"14_CR44","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jcem.85.10.6880","volume":"85","author":"J.C. Smith","year":"2000","unstructured":"Smith JC, Page MM, John R, et al.: Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85:3515\u20133519.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","volume":"90","author":"M.R. Rubin","year":"2005","unstructured":"Rubin MR, Maurer MS, McMahon DJ, et al.: Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrin Metabol 2005, 90:3326\u20133330.","journal-title":"J Clin Endocrin Metabol"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.surg.2003.07.017","volume":"134","author":"I.L. Nilsson","year":"2003","unstructured":"Nilsson IL, Aberg J, Rastad J, Lind L: Circadian cardiac autonomic nerve dysfunction in primary hyperparathyroidism improves after parathyroidectomy. Surgery 2003, 134:1013\u20131019.","journal-title":"Surgery"},{"key":"14_CR47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.0.1470453","volume":"147","author":"V. Nuzzo","year":"2002","unstructured":"Nuzzo V, Tauchmanova L, Fonderico F, et al.: Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 2002, 147:453\u2013459.","journal-title":"Eur J Endocrinol"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2006-925135","volume":"38","author":"F. Fallo","year":"2006","unstructured":"Fallo F, Cella G, Casonato A, et al.: Biochemical markers of endothelial activation in primary hyperparathyroidism. Horm Metab Res 2006, 38:125\u2013129.","journal-title":"Horm Metab Res"},{"key":"14_CR49","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/ndt\/gfm269","volume":"22","author":"G. Rashid","year":"2007","unstructured":"Rashid G, Bernheim J, Green J, et al.: Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant 2007, 22:2831\u20132837.","journal-title":"Nephrol Dial Transplant"},{"key":"14_CR50","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1210\/endo.136.6.7750471","volume":"136","author":"M.D. Nyby","year":"1995","unstructured":"Nyby MD, Hino T, Berger ME, et al.: Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 1995, 136:2497\u20132504.","journal-title":"Endocrinology"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1365-2168.2000.01575.x","volume":"87","author":"D.R. Chadwick","year":"2000","unstructured":"Chadwick DR, Harrison BJ, Chan P, et al.: Vasoactive and proliferative effects of parathyroid hormone and parathyroid hormone-related peptide on human vascular smooth muscle. Br J Surg 2000, 87:1529\u20131533.","journal-title":"Br J Surg"},{"key":"14_CR52","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D. Somjen","year":"2005","unstructured":"Somjen D, Weisman Y, Kohen F, et al.: 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666\u20131671.","journal-title":"Circulation"},{"key":"14_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000069761","volume":"26","author":"V. Perkovic","year":"2003","unstructured":"Perkovic V, Hewitson TD, Kelynack KJ, et al.: Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 2003, 26:27\u201333.","journal-title":"Kidney Blood Press Res"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jcb.20424","volume":"95","author":"J.F. Whitfield","year":"2005","unstructured":"Whitfield JF: Osteogenic PTHs and vascular ossification\u2014is there a danger for osteoporotics? J Cell Biochem 2005, 95:437\u2013444.","journal-title":"J Cell Biochem"},{"key":"14_CR55","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.ATV.17.6.1135","volume":"17","author":"S. Jono","year":"1997","unstructured":"Jono S, Nishizawa Y, Shioi A, et al.: Parathyroid hormone-related peptide as a local regulator of vascular calcification. Arterioscler Thromb Vasc Biol 1997, 17:1135\u20131142.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2265.2005.02363.x","volume":"63","author":"C.G. Ogard","year":"2005","unstructured":"Ogard CG, Engelmann MD, Kistorps C, et al.: Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol 2005, 63:493\u2013498.","journal-title":"Clin Endocrinol"},{"key":"14_CR57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E. Delfini","year":"2007","unstructured":"Delfini E, Petramala L, Caliumi C, et al.: Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 2007, 56:30\u201336.","journal-title":"Metabolism"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-008-0014-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-008-0014-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T18:17:53Z","timestamp":1738433873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-008-0014-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11914-008-0014-8","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}